At its core, it's a peptide complex
By activating GLP-1 receptors in the body, these medications help individuals in several important ways: Curbing appetite : They signal the brain to promote a feeling of fullness, which helps reduce food intake and minimize cravings
Finally, Aspiration considers these companies value propositions, available patents, real-world impact and clinical studies of their solutions, and total market potential, while concurrently considering their ongoing commitment to leveraging AI and ML algorithms
Mechanisms Explaining these Outcomes Weight Loss and Satiety: GLP-1 agonists act on the brain and gut to reduce appetite, increase satiety , and slow gastric emptying
A pre-specified meta-analysis including all the seven clinical trials that constituted the clinical development program of tirzepatide (SURPASS) demonstrated its CV safety in patients with T2DM in terms of not increasing the risk of major adverse CV events (MACE)